elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24240165-A8180054-5EC6-40DF-8B41-2F252E2E22DA
Q24240165-A8180054-5EC6-40DF-8B41-2F252E2E22DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24240165-A8180054-5EC6-40DF-8B41-2F252E2E22DA
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema
P2860
Q24240165-A8180054-5EC6-40DF-8B41-2F252E2E22DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24240165-A8180054-5EC6-40DF-8B41-2F252E2E22DA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
aa30c65f35731457b05afbc6911f7e7c6544c1bb
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer